A Phase 2, Open-Label, Multicenter Study to Assess the Safety and Efficacy of Certolizumab Pegol in Children and Adolescents with Active Crohn's Disease

  • Shashidhar, Harohalli (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/12/103/31/12